Guest guest Posted October 27, 2003 Report Share Posted October 27, 2003 > > SARS - WORLDWIDE (176): SEROSURVEY CHINA ANIMAL TRADERS > *************************************** > A ProMED-mail post > <http://www.promedmail.org> > ProMED-mail is a program of the > International Society for Infectious Diseases > <http://www.isid.org> > > 16 Oct 2003 > ProMED-mail <promed > Source: Morbidity Mortality Weekly Report 17 Oct 2003 52(41);986-987 [edited] > <http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5241a2.htm> > > > Prevalence of IgG Antibody to SARS-Associated Coronavirus in Animal Traders > -- Guangdong Province, China, 2003 > --------------------------- > Severe acute respiratory syndrome (SARS) was identified in 2003 as an > infectious disease caused by the SARS-associated coronavirus (SARS-CoV), a > member of the coronavirus family not observed previously in humans (1,2). > Because its sequence data differ from those of known human coronaviruses, > SARS-CoV is suspected to have crossed the species barrier between an animal > host and humans. > > The SARS outbreak began in China's Guangdong Province, where approximately > 1500 probable cases were identified during November 2002--June 2003 (3). > Detection of SARS-like coronavirus has been reported previously in masked > palm civets (sometimes called civet cats) and a raccoon dog for sale in a > live animal market in Shenzhen municipality (4). > > This report summarizes results of an investigation conducted by public > health authorities in Guangdong Province, which compared the seroprevalence > of SARS-CoV IgG antibody in animal traders (i.e., workers in live animal > markets) with that of persons in control groups. The results indicated that > 13 percent of the animal traders, none of whom had SARS diagnosed, had IgG > antibody to SARS-CoV, compared with 1-3 percent of persons in 3 control > groups. Although the results provide indirect support for the hypothesis of > an animal origin for SARS, they also underscore the need for detailed > patient histories and more focused animal studies to confirm an animal > origin for SARS. > > The seroprevalence study was conducted by the Guangdong Center for Disease > Control and Prevention (CDC) in conjunction with the Guangzhou CDC, Baiyun > District CDC, and Shijing Township Hospital. Traders in 3 animal markets in > Guangzhou, Guangdong Province, were offered participation in the study, and > samples were collected on 4 May 2003 from those who gave consent. The > trader test results were compared with those for persons in 3 control > groups: 1) health-care workers involved with SARS control in 2 city > hospitals, 2) public health workers in the Guangdong CDC facility, and 3) > healthy adults visiting a clinic for routine physical examinations. > Compared with the overall control population, the animal traders were more > likely to be male and older; the majority of persons in both the trader and > control groups were aged 20-39 years. A sample of blood (5 mL) was drawn > from each subject, and IgG antibody to SARS-CoV was tested by enzyme-linked > immunosorbent assay (ELISA) by using the test kit (batch no. 20030501) > manufactured by Beijing Huada GBI Biotechnology Co. Ltd., Beijing. > > Of 792 persons tested, IgG antibody to SARS-CoV was detected in 72 (9.1 > percent). Positive rates were highest in the trader group (13.0 percent), > compared with the 3 control groups (range: 1.2-2.9 percent) (Table 1 > below). The prevalence of IgG antibody in the trader group was > statistically significantly higher than that of the overall control > population (chi square = 26.1; p<0.01). In contrast, no statistically > significant difference was determined in the prevalence of antibody > detected among the 3 control groups (chi square = 0.89; p = 0.64). > > Among animal traders, the highest prevalence of antibody was found among > those who traded primarily masked palm civets (72.7 percent), wild boars > (57.1 percent), muntjac deer (56.3 percent), hares (46.2 percent), and > pheasant (33.3 percent) (Table 2). The prevalence of traders with IgG > antibody to SARS-CoV varied by market (6 percent, 11 percent, and 20 > percent, respectively; p<0.001); no correlation was found between SARS-CoV > antibody and sex, age, or number of years worked in a live animal market. > None of the subjects had SARS or atypical pneumonia diagnosed during the > Guangdong Province outbreak. > > Reported by: D Yu, MD, H Li, R Xu, MPH, J He, J Lin, L Li, W Li, H Xu, S > Huang, J Huang, Guangdong Center for Disease Control, Guangzhou, China. > > MMWR Editorial Note: > > This study found serologic evidence suggesting that asymptomatic infection > with SARS-CoV or an antigenically related virus occurred in Guangdong > Province. Seroprevalence of IgG antibody to SARS-CoV was substantially > higher among traders of live animals than among persons in control groups, > consistent with the hypothesis that SARS-CoV crossed the species barrier > from animals to humans. The results are consistent with preliminary > determinations of a joint research team from China's Ministry of > Agriculture and Guangdong Province, which found that sequences of > coronavirus detected by polymerase chain reaction in bats, monkeys, masked > palm civets, and snakes were identical to or similar to those of human > SARS-CoV isolates. In addition, a joint study by Shenzhen CDC and Hong Kong > University determined that the sequence of coronavirus isolated from masked > palm civets is 99 percent identical to human SARS-CoV (4). These > determinations appear consistent with the hypothesis that an animal > reservoir exists for SARS-CoV or an antigenically related virus; however, > the findings are not sufficient to identify either the natural reservoir > for SARS-CoV or the animal(s) responsible for crossover to humans. > > Primary modes of SARS transmission probably are direct contact or droplet > spread from a patient symptomatic with SARS; however, other routes of > transmission might exist (5). Approximately 63 percent of Guangdong > Province patients with clinically defined SARS had no known history of > exposure to other SARS patients, and the percentage increased after April > 2003 (6). This trend of unknown exposure also was observed in other areas > (7). Therefore, the possibility of unrecognized sources of infection or > infection from asymptomatic carriers of the virus cannot be excluded, > although some patients might also have pneumonia caused by etiologies other > than SARS-CoV. > > The findings in this report are subject to at least 4 limitations. 1st, > although subjects were categorized as primarily traders of the animals they > were selling at the time of the survey, a substantial portion traded or > handled more than one type of animal. 2nd, the small number of subjects > with reported exposure to certain types of animals limits the ability to > differentiate risk among specific groups of animal traders. 3rd, although > the animal traders worked at 3 markets in Guangzhou, risk might differ > among traders in other parts of Guangdong Province or elsewhere in China. > Finally, as with other urgently developed tests, validation of the ELISA > kit employed has not been completed, and the IgG antibody cannot > distinguish recent from remote infection. > > This report provides indirect support for the hypothesis that SARS-CoV > might have originated from an animal source and identifies multiple animals > for further study. However, none of the traders in this study had SARS, and > only 2 SARS patients in Guangdong Province were identified as animal > traders (i.e., a snake seller and a pigeon seller) (6). In contrast, > comparative analysis of early Guangdong cases, unlinked to other SARS > cases, indicated an overrepresentation of food handlers (6). Whether the > antibody detected in the animal traders in this report might represent > infection with a related coronavirus that cross-reacts with SARS-CoV, or > whether that antibody provides protection from SARS, is not known. Efforts > to identify a possible animal reservoir for SARS might benefit from prompt > attention to collecting detailed histories from any future SARS patients > regarding animal and other environmental exposures and initiating > tracebacks to animal supply sources (e.g., markets, farms, and wildlife areas). > > Acknowledgments > > This report was based on contributions by Guangzhou Municipal Center for > Disease Control (CDC), Baiyun District CDC; Shijing Township Hospital, > Guangdong Province; CK Lee, MD, World Health Organization (WHO)--China SARS > Team, Beijing, China. A Schuchat, MD, WHO-China SARS Team and National > Center for Infectious Diseases, CDC. > > References > > 1. Drosten C, Gunther S, Preiser W, et al. Identification of a novel > coronavirus in patients with severe acute respiratory syndrome. N Engl J > Med 2003;348:1967--76. > 2. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus > associated with severe acute respiratory syndrome. N Engl J Med > 2003;348:1953--66. > 3. Li LH, Peng GW, Liang WJ, et al. Epidemiological analysis on SARS > clustered cases in Guangdong province. South China J Prev Med 2003;29:3--5. > 4. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of > viruses related to the SARS coronavirus from animals in southern China. > Science 2003;302:276--8. > 5. Ng SK. Possible role of an animal vector in the SARS outbreak at Amoy > Gardens. Lancet 2003;362:570--2. > 6. He JF, Xu RH, Yu DW, et al. Severe acute respiratory syndrome in > Guangdong Province of China: epidemiology and control measures. Chin J Prev > Med 2003;37:227--32. > 7. Beijing Joint SARS Expert Group. Large outbreak of severe acute > respiratory syndrome (SARS) in Beijing, 2003. Emerg Infect Dis (in press). > > Table 1 - Prevalence of IgG antibody to SARS-associated coronavirus in > animal traders and persons in 3 control groups -- Guangdong Province, > China, 2003 > > Group: No. tested / Testing positive (No./percent) > Animal traders 508 / (66/ 13.0) > Hospital workers 137 / (4/ 2.9) > Guangdong CDC workers 63 / (1/1.6) > Healthy adults in clinic 84 / (1/1.2) > > Chi square 26.1 p less than 0.02 animal traders versus other groups > > > Table 2 - Prevalence of IgG antibody to SARS-associated coronavirus in > selected animal traders, by primary animal traded -- Guangdong Province, > China, 2003 > > Primary animal traded *: No. traders/ testing positive (No./percent) / > relative risk/ (95 percent CI) > Masked palm civet: 22/ (16/ 72.7) / 7.9 / (5.0-12.6) > Wild boar 28/ (16/ 57.1) / 6.2 / (3.8-10.3) > Muntjac deer 16/ (9/ 56.3) / 6.1 / (3.4-10.9) > Hare 13/ (6/ 46.2) / 5.0 / (2.5-10.2) > Pheasant 9/ (3/33.3)/ 4.9 / (0.7-24.8) ** > Cat 43/ (8/ 18.6)/ 2.0 (1.0-4.2) > Other fowl 25/ (3/ 12.0)/ .3 (o.2-5.0) ** > Snake 250/ (23/ 9.2)/ Reference group > > * Categories not mutually exclusive, except for snakes > ** Odds ratio and 95 percent confidence interval by Fisher exact test > > -- > ProMED-mail > <promed > > [These data are interesting and tantalizing although not definitive. In > addition to the questions posed in the discussion above, there is the > question of asymptomatic infection with the SARS-associated coronavirus > (SARS-CoV), and its relevance to possible transmission. Anecdotal > information (hearsay) gathered by this moderator is that some individuals > with positive IgG for the SARS-CoV (presumed to be indicative of prior > infection with the virus) when interviewed were noted to have had a history > of respiratory illness, but in the absence of hospitalization, were not > considered to have had " the disease " . > > It would be interesting to know whether the definition used in the above > study for diagnosis of " SARS or atypical pneumonia " in the study group was > based on a systematic interview of study participants to determine whether > there had been a history of a significant respiratory illness on the part > of those animal traders with IgG evidence of infection with the SARS-CoV, > or whether illness was defined as having been hospitalized with a diagnosis > of SARS. - Mod.MPP] > > [see also: > SARS - worldwide (175): antibody survey, China 20030924.2412 > SARS - worldwide (131): diagnostic testing 20030603.1359 > SARS - worldwide (87): case definitions and diagnostics 20030502.1103 > SARS - worldwide (42): WHO historical overview 20030411.0878 > SARS - worldwide (41):overview 20030411.0876] > ....................mpp/pg/dk > > > *##########################################################* > ProMED-mail makes every effort to verify the reports that > are posted, but the accuracy and completeness of the > information, and of any statements or opinions based > thereon, are not guaranteed. The reader assumes all risks in > using information posted or archived by ProMED-mail. ISID > and its associated service providers shall not be held > responsible for errors or omissions or held liable for any > damages incurred as a result of use or reliance upon posted > or archived material. > ************************************************************ > * * > * Please support the 2003 ProMED-mail Internet-a-thon! * > * http://www.isid.org/netathon2003.shtml * > * * > ************************************************************ > Visit ProMED-mail's web site at <http://www.promedmail.org>. > Send all items for posting to: promed > (NOT to an individual moderator). If you do not give your > full name and affiliation, it may not be posted. Send > commands to /, get archives, help, > etc. to: majordomo. For assistance from a > human being send mail to: owner-promed. > ############################################################ > ############################################################ > -- Dave Neale Animals Asia Foundation Find out more about the historic China Bear Rescue by visiting the Animals Asia Foundation website at http://www.animalsasia.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.